What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?

Каков современный статус хондроитина сульфата и глюкозамина в лечении остеоартрита коленного сустава?
Ali Mobasheri, Yves Henrotin, Marc Marty
2014-05-01

chondroitin sulfateextracellular cartilage matrixglucosamine sulfatejoint space narrowingknee osteoarthritis
Chondroitin sulfate and glucosamine sulfate exert beneficial effects on the metabolism of in vitro models of cells derived from synovial joints: chondrocytes, synoviocytes and cells from subchondral bone, all of which are involved in osteoarthritis (OA). They increase type II collagen and proteoglycan synthesis in human articular chondrocytes and are able to reduce the production of some pro-inflammatory mediators and proteases, to reduce the cellular death process, and improve the anabolic/catabolic balance of the extracellular cartilage matrix (ECM). Clinical trials have reported a beneficial effect of chondroitin sulfate and glucosamine sulfate on pain and function. The structure-modifying effects of these compounds have been reported and analyzed in recent meta-analyses. The results for knee OA demonstrate a small but significant reduction in the rate of joint space narrowing. Chondroitin sulfate and glucosamine sulphate are recommended by several guidelines from international societies for the management of knee and hip OA, while others do not recommend these products or recommend only under condition. This comprehensive review clarifies the role of these compounds in the therapeutic arsenal for patients with knee OA.
1
Chondroitin sulfate and glucosamine sulfate improve metabolism in osteoarthritis-relevant chondrocytes, synoviocytes, and subchondral bone cells.
2
Clinical trials report beneficial effects on knee osteoarthritis pain and function.
3
In human articular chondrocytes, both compounds increase type II collagen and proteoglycan synthesis while reducing selected inflammatory mediators, proteases, and cellular death.
4
Meta-analyses show a small but significant reduction in knee joint-space narrowing, although international guidelines differ in recommending these treatments.
5
These agents improve the anabolic-to-catabolic balance of the extracellular cartilage matrix in vitro.

chondroitin sulfate and glucosamine sulfate for the treatment of knee osteoarthritis

their effects on joint-cell metabolism, osteoarthritis symptoms and function, cartilage extracellular-matrix balance, and structural joint-space narrowing

Publication Details
Publication Date
2014-05-01
Journal
Publisher
ISSN
Cited by
151
Access Type
Author Information
Authors
Ali Mobasheri
Yves Henrotin
Marc Marty
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%